115 related articles for article (PubMed ID: 6159337)
21. Tissue localization of zinc glycinate marker and carcinoembryonic antigen by immunofluorescence. II. Immunofluorescence microscopy.
Doos WG; Saravis CA; Pusztaszeri G; Burke B; Oh SK; Zamcheck N; Gottlieb LS
J Natl Cancer Inst; 1978 Jun; 60(6):1375-82. PubMed ID: 349170
[TBL] [Abstract][Full Text] [Related]
22. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
Gulyás M; Elek G; Molnár M; Szollár L
Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
[TBL] [Abstract][Full Text] [Related]
23. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
24. Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions.
To A; Dearnaley DP; Ormerod MG; Canti G; Coleman DV
Am J Clin Pathol; 1982 Aug; 78(2):214-9. PubMed ID: 6179426
[TBL] [Abstract][Full Text] [Related]
25. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
26. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of lysozyme, alpha 1-anti-chymotrypsin, tissue polypeptide antigen, keratin and carcinoembryonic antigen in effusion sediments.
Permanetter W; Wiesinger H
Acta Cytol; 1987; 31(2):104-12. PubMed ID: 2435101
[TBL] [Abstract][Full Text] [Related]
28. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
Sthaneshwar P; Yap SF; Jayaram G
Malays J Pathol; 2002 Jun; 24(1):53-8. PubMed ID: 16329556
[TBL] [Abstract][Full Text] [Related]
30. [Use of immunohistochemistry in clinical cytology].
Weintraub D; Weintraub J; Vassilakos P
Ann Pathol; 1987; 7(1):25-30. PubMed ID: 3304314
[TBL] [Abstract][Full Text] [Related]
31. [Differential diagnosis of pleural effusions].
Ogino M; Koike K; Satoh K; Arai K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
[TBL] [Abstract][Full Text] [Related]
32. Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.
Walts AE; Said JW
Acta Cytol; 1983; 27(4):408-16. PubMed ID: 6410636
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
34. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
[TBL] [Abstract][Full Text] [Related]
36. [Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan No Rinsho; 1986 Jul; 32(8):895-9. PubMed ID: 2427754
[TBL] [Abstract][Full Text] [Related]
37. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
Saad RS; Cho P; Liu YL; Silverman JF
Diagn Cytopathol; 2005 Mar; 32(3):156-9. PubMed ID: 15690334
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
39. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Emmanouilidou AG; Athanassiadis PP
Acta Cytol; 1985; 29(1):57-62. PubMed ID: 3881880
[TBL] [Abstract][Full Text] [Related]
40. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
